Skip to main content
. 2018 Oct 4;13(10):e0204859. doi: 10.1371/journal.pone.0204859

Fig 2. Cumulative all-cause mortality between metformin users and nonusers of patients with T2DM and stable (log-rank test, p < 0.0001) or exacerbated COPD (log-rank test, p < 0.0001) by Kaplan–Meier curve.

Fig 2